Skip to content
Back to RTSN

Retension Pharmaceuticals, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
2
Purchases
2
Sales
0
Purchase value
$369.60K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Eric L. KellerDirector · CHIEF EXECUTIVE OFFICER
4
Filed Oct 13, 2026Period of report Oct 13, 20260001213900-26-109160
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 13, 2026
Common Stock20,800$12.00$249.60K423,377Direct
Filing footnotes · 3
  1. F1Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date.
  2. F2Each share of Series B Convertible Preferred Stock (the "Series B Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date.
  3. F3Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on August 14, 2027, with the remaining stock options vesting in 36 monthly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Open on SEC EDGAR
Franklin M BergerDirector
4
Filed Oct 13, 2026Period of report Oct 13, 20260001213900-26-109155
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 13, 2026
Common Stock10,000$12.00$120.00K10,000IndirectBy FMB Research
Filing footnotes · 1
  1. F1Each share of Series B Convertible Preferred Stock (the "Series B Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.